Subclinical Impairment of Cardiovascular System in Patients With Psoriasis
NCT05957120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-07-24
Summary
A cross-sectional study will be conducted, which will include 80 young patients with psoriasis, aged 30-45 years, treated with five different types of antipsoriatic treatment, and 20 healthy patients. All 100 subjects will be subjected to anthropometric measurements, blood will be collected for laboratory tests, and an imaging test will be performed to determine the function of the endothelium and arterial stiffness. The results will then be statistically analyzed.
Conditions
- Psoriasis
- Inflammation
- Endothelial Dysfunction
- Metabolic Disturbance
- Insulin Resistance
- Coagulation Disorder
- Thrombocyte Disorders
Sponsors & Collaborators
-
University Medical Centre Ljubljana
lead OTHER
Principal Investigators
-
Eva Klara Merzel Sabovic, MD · University Medical Centre Ljubljana
Eligibility
- Min Age
- 30 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-03
- Primary Completion
- 2022-09-01
- Completion
- 2022-11-30
Countries
- Slovenia
Study Locations
More Related Trials
-
Study of Psoriatic Arthritis
NCT00001420 ·Status: COMPLETED
-
Premature Coronary Artery Disease (CAD) in Severe Psoriasis
NCT00893126 ·Status: COMPLETED
-
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
NCT04950218 ·Status: RECRUITING
-
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
NCT01356758 ·Status: COMPLETED
-
Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.
NCT01753245 ·Status: UNKNOWN
-
Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis
NCT05125679 ·Status: TERMINATED ·Phase: PHASE4
-
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
NCT01555606 ·Status: COMPLETED
-
Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.
NCT01320293 ·Status: COMPLETED ·Phase: NA
-
Immune Metabolic Associations in Psoriatic Arthritis
NCT03399708 ·Status: COMPLETED
-
MIcrovascular dysfuNction In Moderate-severe Psoriasis
NCT04271540 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
NCT05701995 ·Status: COMPLETED ·Phase: PHASE4
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance
NCT06165887 ·Status: NOT_YET_RECRUITING
-
Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients
NCT05683015 ·Status: RECRUITING ·Phase: PHASE4
-
Cytokines and Vascular Inflammation in Psoriasis
NCT02305953 ·Status: COMPLETED
-
A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
NCT07149792 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis
NCT02595970 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
NCT02330380 ·Status: COMPLETED
-
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
NCT04776629 ·Status: COMPLETED ·Phase: PHASE2
-
Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis
NCT03889938 ·Status: UNKNOWN
-
Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis
NCT02690701 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Secukinumab in the Treatment of Psoriatic Arthritis
NCT02854163 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
NCT05925842 ·Status: UNKNOWN
-
Long-Term Follow-Up Study of Psoriasis Patients
NCT00131066 ·Status: COMPLETED
-
The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis
NCT05589298 ·Status: COMPLETED